NCT03432936
Prospective Use of Philips iSuite for Interventional Procedures
Enrolling by Invitation
NAAges 18–90InterventionalDevice feasibilityMayo ClinicInvestigator-initiated
~12 participants
Updated 2026-04-01 on ClinicalTrials.gov
What's tested:MRI guided procedure software evaluation
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Needle placement efficiency into target lesion
Measured over Baseline (completion of MRI-guided biopsy and /or ablation procedure)
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- David A Woodrum, M.D., Ph.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients already scheduled for a percutaneous MR guided procedure
Exclusion
Pregnant Women
What this trial measures
- Needle placement efficiency into target lesionBaseline (completion of MRI-guided biopsy and /or ablation procedure)
Needle placement efficiency record time to final needle position, and compare overall similarity of use with current CT guided intervention during the interventional procedure in order to determine how the iSuite may facilitate intervention with the MRI environment. Each operator will fill out a short questionnaire after each intervention.